The Hypoglycemic Drugs Market is estimated to be valued at US$ 720.72 Mn in 2023 and is expected to exhibit a CAGR of 9.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
The Hypoglycemic Drugs Market is witnessing high growth owing to increasing prevalence of diabetes. Diabetes is a chronic disease that occurs when blood glucose level is high due to insulin deficiency or when body ... Read more
